Published in J Pathol on January 01, 2006
Inflammation, atrophy, and gastric cancer. J Clin Invest (2007) 4.29
Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev (2010) 3.41
Fibroblast heterogeneity in the cancer wound. J Exp Med (2014) 2.09
Pathology of gastric intestinal metaplasia: clinical implications. Am J Gastroenterol (2010) 1.84
Role of innate immunity in Helicobacter pylori-induced gastric malignancy. Physiol Rev (2010) 1.73
Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing. Gastroenterology (2006) 1.68
Role of the cag-pathogenicity island encoded type IV secretion system in Helicobacter pylori pathogenesis. FEBS J (2011) 1.68
A global overview of the genetic and functional diversity in the Helicobacter pylori cag pathogenicity island. PLoS Genet (2010) 1.64
Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment. World J Gastroenterol (2014) 1.51
Helicobacter pylori dysregulation of gastric epithelial tight junctions by urease-mediated myosin II activation. Gastroenterology (2008) 1.41
Helicobacter pylori counteracts the apoptotic action of its VacA toxin by injecting the CagA protein into gastric epithelial cells. PLoS Pathog (2009) 1.40
Senescent stromal-derived osteopontin promotes preneoplastic cell growth. Cancer Res (2009) 1.38
Helicobacter pylori cytotoxin-associated gene A activates the signal transducer and activator of transcription 3 pathway in vitro and in vivo. Cancer Res (2009) 1.28
Epidermal growth factor receptor activation protects gastric epithelial cells from Helicobacter pylori-induced apoptosis. Gastroenterology (2009) 1.28
Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease. Semin Radiat Oncol (2013) 1.28
In vitro and in vivo activities of Chios mastic gum extracts and constituents against Helicobacter pylori. Antimicrob Agents Chemother (2006) 1.18
CagA-producing Helicobacter pylori and increased risk of gastric cancer: a nested case-control study in Korea. Br J Cancer (2006) 1.17
Gastric cancer: an infectious disease. Infect Dis Clin North Am (2010) 1.17
Effect of Helicobacter pylori eradication on gastric carcinogenesis. Lab Invest (2008) 1.14
Helicobacter pylori infection, oncogenic pathways and epigenetic mechanisms in gastric carcinogenesis. Future Oncol (2010) 1.14
Helicobacter pylori cag-Pathogenicity island-dependent early immunological response triggers later precancerous gastric changes in Mongolian gerbils. PLoS One (2009) 1.14
Phasevarion mediated epigenetic gene regulation in Helicobacter pylori. PLoS One (2011) 1.13
The functional interplay of Helicobacter pylori factors with gastric epithelial cells induces a multi-step process in pathogenesis. Cell Commun Signal (2013) 1.11
Helicobacter pylori CagL activates ADAM17 to induce repression of the gastric H, K-ATPase alpha subunit. Gastroenterology (2010) 1.11
Nox enzymes and oxidative stress in the immunopathology of the gastrointestinal tract. Semin Immunopathol (2008) 1.11
Prediction of extracellular proteases of the human pathogen Helicobacter pylori reveals proteolytic activity of the Hp1018/19 protein HtrA. PLoS One (2008) 1.10
Connection between inflammation and carcinogenesis in gastrointestinal tract: focus on TGF-beta signaling. World J Gastroenterol (2010) 1.06
Identification of markers for Helicobacter pylori strains isolated from children with peptic ulcer disease by suppressive subtractive hybridization. Infect Immun (2006) 1.06
Prevention strategies for gastric cancer: a global perspective. Clin Endosc (2014) 1.04
The role of viral and bacterial pathogens in gastrointestinal cancer. J Cell Physiol (2008) 1.02
Comparative genomics and proteomics of Helicobacter mustelae, an ulcerogenic and carcinogenic gastric pathogen. BMC Genomics (2010) 1.02
Delineation of a carcinogenic Helicobacter pylori proteome. Mol Cell Proteomics (2009) 1.00
Dendritic cells the tumor microenvironment and the challenges for an effective antitumor vaccination. J Biomed Biotechnol (2012) 0.98
Gastric carcinogenesis. World J Gastroenterol (2012) 0.97
Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy. Oncotarget (2015) 0.97
Aging and inflammation: etiological culprits of cancer. Curr Aging Sci (2009) 0.97
Relationship of IL-1 and TNF-α polymorphisms with Helicobacter pylori in gastric diseases in a Brazilian population. Braz J Med Biol Res (2012) 0.96
Epigenetic regulation of inflammatory cytokines and associated genes in human malignancies. Mediators Inflamm (2015) 0.93
Tobacco exposure by various modes may alter proinflammatory (IL-12) and anti-inflammatory (IL-10) levels and affects the survival of prostate carcinoma patients: an explorative study in North Indian population. Biomed Res Int (2014) 0.93
Variations in Helicobacter pylori cytotoxin-associated genes and their influence in progression to gastric cancer: implications for prevention. PLoS One (2012) 0.92
IL-11 is a parietal cell cytokine that induces atrophic gastritis. Gut (2011) 0.92
"Targeted disruption of the epithelial-barrier by Helicobacter pylori". Cell Commun Signal (2011) 0.92
Evolutionary History of the Helicobacter pylori Genome: Implications for Gastric Carcinogenesis. Gut Liver (2012) 0.92
The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease. Clin Transl Gastroenterol (2015) 0.92
Helicobacter pylori-induced histone modification, associated gene expression in gastric epithelial cells, and its implication in pathogenesis. PLoS One (2010) 0.91
Tobacco exposure may enhance inflammation in prostate carcinoma patients: an explorative study in north Indian population. Toxicol Int (2012) 0.91
Histopathological profile of gastritis in adult patients seen at a referral hospital in Kenya. World J Gastroenterol (2007) 0.90
Helicobacter pylori outer membrane protein HopQ identified as a novel T4SS-associated virulence factor. Cell Microbiol (2013) 0.90
Selenoprotein S (SEPS1) gene -105G>A promoter polymorphism influences the susceptibility to gastric cancer in the Japanese population. BMC Gastroenterol (2009) 0.90
Molecular cross-talk between Helicobacter pylori and human gastric mucosa. World J Gastroenterol (2011) 0.90
Benign, premalignant, and malignant lesions encountered in bariatric surgery. JSLS (2013) 0.90
Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1. Oncotarget (2016) 0.89
Increased expression of the urokinase plasminogen activator system by Helicobacter pylori in gastric epithelial cells. Am J Physiol Gastrointest Liver Physiol (2008) 0.89
β-Cryptoxanthin supplementation prevents cigarette smoke-induced lung inflammation, oxidative damage, and squamous metaplasia in ferrets. Cancer Prev Res (Phila) (2011) 0.89
ERBBs in the gastrointestinal tract: recent progress and new perspectives. Exp Cell Res (2008) 0.89
Helicobacter pylori Outer Membrane Protein 18 (Hp1125) Is Involved in Persistent Colonization by Evading Interferon- γ Signaling. Biomed Res Int (2015) 0.89
Helicobacter pylori: Eradication or Preservation. F1000 Med Rep (2012) 0.89
Helicobacter pylori and mitogen-activated protein kinases mediate activator protein-1 (AP-1) subcomponent protein expression and DNA-binding activity in gastric epithelial cells. FEMS Immunol Med Microbiol (2008) 0.88
Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesis. World J Gastroenterol (2015) 0.87
Inflammation to cancer: The molecular biology in the pancreas (Review). Oncol Lett (2014) 0.86
Factors that mediate colonization of the human stomach by Helicobacter pylori. World J Gastroenterol (2014) 0.86
The detection of Helicobacter pylori cag pathogenicity islands (PAIs) and expression of matrix metalloproteinase-7 (MMP-7) in gastric epithelial dysplasia and intramucosal cancer. Gastric Cancer (2010) 0.86
Helicobacter pylori infection induced gastric cancer; advance in gastric stem cell research and the remaining challenges. Gut Pathog (2012) 0.86
In vivo expression of Helicobacter pylori virulence genes in patients with gastritis, ulcer, and gastric cancer. Infect Immun (2011) 0.86
Complex cellular responses of Helicobacter pylori-colonized gastric adenocarcinoma cells. Infect Immun (2011) 0.85
No association between Epstein-Barr Virus and Mouse Mammary Tumor Virus with breast cancer in Mexican women. Sci Rep (2013) 0.85
Perspectives on reprograming cancer-associated dendritic cells for anti-tumor therapies. Front Oncol (2014) 0.84
Helicobacter pylori infection and disease: from humans to animal models. Dis Model Mech (2008) 0.84
Comparative genomic analysis of Helicobacter pylori from Malaysia identifies three distinct lineages suggestive of differential evolution. Nucleic Acids Res (2014) 0.84
Association between Helicobacter spp. infections and hepatobiliary malignancies: a review. World J Gastroenterol (2015) 0.83
Identification of E-cadherin signature motifs functioning as cleavage sites for Helicobacter pylori HtrA. Sci Rep (2016) 0.83
Hematologic manifestations of Helicobacter pylori infection. World J Gastroenterol (2014) 0.83
Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients. J Cancer Res Clin Oncol (2014) 0.83
The stability and activity of recombinant Helicobacter pylori HtrA under stress conditions. J Basic Microbiol (2012) 0.83
Role of the tumor microenvironment in the pathogenesis of gastric carcinoma. World J Gastroenterol (2014) 0.83
Epigenetic regulation of microRNAs in gastric cancer. Dig Dis Sci (2013) 0.83
Phosphatidylethanolamine of Helicobacter pylori functions as a steroid-binding lipid in the assimilation of free cholesterol and 3β-hydroxl steroids into the bacterial cell membrane. J Bacteriol (2012) 0.82
Helicobacter pylori strains vary cell shape and flagellum number to maintain robust motility in viscous environments. Mol Microbiol (2015) 0.81
Prevalence of virulence-associated genotypes of Helicobacter pylori and correlation with severity of gastric pathology in patients from western Sicily, Italy. Eur J Clin Microbiol Infect Dis (2008) 0.81
Decreased fructose-1,6-bisphosphatase-2 expression promotes glycolysis and growth in gastric cancer cells. Mol Cancer (2013) 0.81
Unintended consequences of Helicobacter pylori infection in children in developing countries: iron deficiency, diarrhea, and growth retardation. Gut Microbes (2013) 0.81
A clinical perspective on the role of chronic inflammation in gastrointestinal cancer. Clin Exp Gastroenterol (2014) 0.81
Helicobacter pylori infection and eye diseases: a systematic review. Medicine (Baltimore) (2014) 0.80
Helicobacter pylori infection: new pathogenetic and clinical aspects. World J Gastroenterol (2014) 0.80
Detoxification of 7-dehydrocholesterol fatal to Helicobacter pylori is a novel role of cholesterol glucosylation. J Bacteriol (2012) 0.80
Helicobacter pylori in gastric carcinogenesis. World J Gastrointest Oncol (2015) 0.80
Molecular Interactions between MUC1 Epithelial Mucin, β-Catenin, and CagA Proteins. Front Immunol (2012) 0.80
An Update on Helicobacter pylori as the Cause of Gastric Cancer. Gastrointest Tumors (2014) 0.80
The Microbiome and Cancer: Is the 'Oncobiome' Mirage Real? Trends Cancer (2015) 0.80
Origins of injection-site sarcomas in cats: the possible role of chronic inflammation-a review. ISRN Vet Sci (2011) 0.79
Mutual amplification of HNF4α and IL-1R1 composes an inflammatory circuit in Helicobacter pylori associated gastric carcinogenesis. Oncotarget (2016) 0.79
Effect of Helicobacter pylori on gastric epithelial cells. World J Gastroenterol (2014) 0.79
Effect of Helicobacter pylori Infection on the Composition of Gastric Microbiota in the Development of Gastric Cancer. Gastrointest Tumors (2015) 0.78
Helicobacter pylori colonization in Nepal; assessment of prevalence and potential risk factors in a hospital-based patient cohort. BMC Res Notes (2016) 0.78
Role of Helicobacter pylori in gastric cancer: Updates. World J Gastrointest Oncol (2016) 0.78
Herbal extract SH003 suppresses tumor growth and metastasis of MDA-MB-231 breast cancer cells by inhibiting STAT3-IL-6 signaling. Mediators Inflamm (2014) 0.78
What exists beyond cagA and vacA? Helicobacter pylori genes in gastric diseases. World J Gastroenterol (2015) 0.78
Association between Genetic Instability and Helicobacter pylori Infection in Gastric Epithelial Dysplasia. Gastroenterol Res Pract (2012) 0.78
Multiple norovirus infections in a birth cohort in a Peruvian Periurban community. Clin Infect Dis (2013) 2.37
Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies. Gastroenterology (2007) 1.88
Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Int J Cancer (2003) 1.55
The mouse colonizing Helicobacter pylori strain SS1 may lack a functional cag pathogenicity island. Helicobacter (2002) 1.23
Helicobacter pylori and gastric cancer. Curr Opin Gastroenterol (2006) 1.18
Helicobacter pylori-induced epithelial cell signalling in gastric carcinogenesis. Trends Microbiol (2004) 1.13
Childhood Helicobacter pylori infection and growth impairment in developing countries: a vicious cycle? Pediatrics (2007) 1.08
Helicobacter pylori and Schistosoma japonicum co-infection in a Chinese population: helminth infection alters humoral responses to H. pylori and serum pepsinogen I/II ratio. Microbes Infect (2005) 1.00
Dietary habits and gastric cancer risk in north-west Iran. Cancer Causes Control (2011) 0.96
ADAMs (a disintegrin and metalloproteinase) messenger RNA expression in Helicobacter pylori-infected, normal, and neoplastic gastric mucosa. J Infect Dis (2002) 0.95
Gastric Helicobacter infection induces iron deficiency in the INS-GAS mouse. PLoS One (2012) 0.92
Helicobacter pylori-associated hypochlorhydria in children, and development of iron deficiency. J Clin Pathol (2012) 0.91
Regional variation among vacA alleles of Helicobacter pylori in China. J Clin Microbiol (2003) 0.90
Gastric Helicobacter species infection in murine and gerbil models: comparative analysis of effects of H. pylori and H. felis on gastric epithelial cell proliferation. J Infect Dis (2002) 0.89
Long-term infection with Helicobacter felis and inactivation of the tumour suppressor gene p53 cumulatively enhance the gastric mutation frequency in Big Blue transgenic mice. J Pathol (2003) 0.89
In-Cell Western analysis of Helicobacter pylori-induced phosphorylation of extracellular-signal related kinase via the transactivation of the epidermal growth factor receptor. Microbes Infect (2007) 0.87
Helicobacter pylori infection in infants and toddlers in South America: concordance between [13C]urea breath test and monoclonal H. pylori stool antigen test. J Clin Microbiol (2013) 0.86
Increased gastric IL-1β concentration and iron deficiency parameters in H. pylori infected children. PLoS One (2013) 0.85
Iron status and Helicobacter pylori infection in symptomatic children: an international multi-centered study. PLoS One (2013) 0.83
Helicobacter pylori infection: CagA-specific antibodies are associated with clinical outcome, but not with HLA-class II polymorphisms of the host. Int J Med Microbiol (2003) 0.82
Enhanced gastric IL-18 mRNA expression in Helicobacter pylori-infected children is associated with macrophage infiltration, IL-8, and IL-1 beta mRNA expression. Eur J Gastroenterol Hepatol (2008) 0.82
Infection of Mongolian gerbils with Chinese Helicobacter pylori strains. FEMS Immunol Med Microbiol (2003) 0.80
First detected Helicobacter pylori infection in infancy modifies the association between diarrheal disease and childhood growth in Peru. Helicobacter (2014) 0.78
Colonization of gerbils with Helicobacter pylori O-chain-deficient mutant SS1 HP0826::Kan results in gastritis and is associated with de novo synthesis of extended homopolymers. Pathog Dis (2013) 0.77
Helicobacter pylori regulates the expression of inhibitors of DNA binding (Id) proteins by gastric epithelial cells. Microbes Infect (2006) 0.77
Helicobacter pylori cagA genotype and density of colonization in relation to gastric inflammation in children. Eur J Gastroenterol Hepatol (2002) 0.76